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Abstract: 
Multiple sclerosis (MS) is a human demyelinating disease of the central nervous 
system (CNS). Experimental autoimmune encephalomyelitis (EAE) is a commonly used 
animal model to study MS. EAE is induced by injecting mice with myelin proteins or 
peptides combined with immunologic adjuvants.  The animals direct an immune response 
against the injected myelin, which results in attacks against their own CNS tissue. T-
helper lymphocytes, bearing the CD4 molecule, have been shown to cause EAE. 
Clinically, the signs observed in mice with EAE are similar to relapsing-remitting MS 
(RRMS), in which the disease expresses itself in cycles. Mouse strains typically used are 
the B10.PL, SJL and C57BL/6, which are susceptible to EAE, but show different patterns 
of clinical disease. 
In this study, we compared CD4 lymphocyte levels between males and females in 
each of these three strains to elucidate any immunologic differences either between the 
sexes or strains. We used flow cytometry to analyze cell populations on the basis of 
surface marker combinations. SJL mice have lymphocyte populations composed of 
54.5% (females) and 51.8% (males) CD4 cells. These values were found to be 20% 
higher than the CD4 levels of the other two strains, in both sexes. Within a strain, sex 
based immunologic differences were minimal (<4%). These findings offer one possible 
explanation for the increased susceptibility of SJL mice to EAE compared with other 
strains. The findings also suggest that the sexual dimorphism seen after induction of 
disease is not due to an immunologic predisposition of either sex. The application of 
these findings will serve to aid future studies in EAE by providing baseline values. More 
importantly, these results will also be helpful in delineating different human immunologic 
states which predispose to the onset of autoimmune disease. (Supported by Dean’s 
Undergraduate Research Fund Award - College of Biological Sciences, Undergraduate 
Research Scholarship - Colleges of the Arts and Sciences)
Introduction: 
Multiple sclerosis (MS) is the most common of the demyelinating diseases of the 
central nervous system (CNS) and affects over 300,000 persons in the United States 
(Steinman, 1996). In studying MS, the murine animal model of experimental autoimmune 
encephalomyelitis (EAE) is commonly used. EAE is mediated through the action of 
CD4+ T-helper cells in response to activation with neuroantigens derived from CNS 
myelin. Neuroantigens include myelin oligodendrocyte glycoprotein (MOG), proteolipid 
protein (PLP) and myelin basic protein (MBP). The disease can only be induced in select 
strains of laboratory mice by injection of neuroantigens and adjuvants. Susceptible strains 
have been shown to have a bias towards T-helper 1 cytokines (IFN-γ, IL-2) amongst 
CD4+ T-cells (Duong et al., 1994; Butler et al., 2002). Strains commonly used in 
studying EAE are the B10.PL (H-2u), SJL (H-2s) and C57BL/6 (H-2b). 
As with many autoimmune diseases, sexual dimorphism is observed in MS with 
females showing a greater prevalence of the disease than males (Whitacre, 2001). The 
disease presents in various clinical forms including relapsing-remitting MS (RRMS), 
which is more prevalent in females and primary progressive MS (PPMS), which is more 
prevalent in males (Lublin and Reingold, 1996). EAE, like MS, shows sexual 
dimorphism but also differences in disease course depending on the strain selected 
(Papenfuss et al., 2004). The SJL strain exhibits a relapsing-remitting disease pattern 
similar to RRMS and is more severe in females. The B10.PL shows a disease pattern 
similar to PPMS with males showing greater disease severity than females while the 
C57BL/6 strain shows progressive disease with no sex differences (Papenfuss et al., 
2004) (Fig.1). 
The purpose of this study is to elaborate on these findings by comparing naïve 
mice for strain and sex differences in order to discern which cell populations predispose a 
strain/sex to a particular pattern of autoimmune disease. We compared the cell 
populations in lymph nodes and spleens of naïve SJL, B10.PL and C57BL/6 male and 
female mice using flow cytometry. Our results indicate that prior to immunization for 
EAE, there are no sex differences in T-cell populations, nor are differences observed in 
naïve splenocyte populations. However, basal levels of CD4+ cells are higher in the 
lymph nodes of the SJL strain relative to the B10.PL and C57BL/6 strains, while 
immuno-regulatory cell populations are unchanged across strains.  



























































Representative graphs of 
disease course of SJL, 
C57BL/6 and B10.PL 
strains upon induction of 
EAE. 
(Papenfuss TL, Rogers CJ, 
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C57BL/6 Immunized with MOG 35-55 
SJL Immunized with PLP 139-151 
Methods/Materials: 
Mice: 
Male and female B10.PL (H-2u), SJL (H-2s) and C57BL/6 (H-2b) mice, between 
5-9 weeks of age were purchased from Jackson Laboratories (Bar Harbor, ME). Mice 
were housed 5 per cage and were allowed an acclimation period before experimental use.  
 
Isolation of lymph node and spleen: 
Naïve male and female mice of each strain were sacrificed. Spleens and lymph 




Single-cell suspensions were obtained from spleen and lymph nodes and stained 
using fluorescein isothiocyanate- (FITC), phycoerythrin- (PE) and allophycocyanin- 
(APC) conjugated antibodies. Staining was carried out as follows: CD4, CD11b, CD19 
markers were identified using FITC-conjugated mouse antibodies (mAb); CD62L, CD28, 
CD69, CD8, B220, CD80 markers were identified using PE-conjugated mAb; CD25, 
CD3, CD11c were labelled with APC-conjugated mAb (Table 1). Isotype controls were 
matched for florochrome to control for non-specific binding. Cell suspensions (106 cells 
per tube) were incubated with labelled mAb in RPMI medium containing 5% serum for 
40 minutes at 4°C. After incubation, cell suspensions were washed and fixed with 1% 
para-formaldehyde. Stained cells were analyzed on a flow cytometer (FACS Calibur, 





CD3 Pan T-cell marker 
CD4 T-helper cells 
CD8 cytotoxic T-cells 
CD62L naïve marker, homing receptor for lymph nodes 
CD25 
α-chain of IL-2 receptor, found on activated and regulatory T-
cells 
CD69 activation marker 
CD28 costimulatory molecule on T-cells 
CD19 B-cell marker 
CD11b macrophage marker 
CD11c dendritic cell marker 
B220 B-cell and plasmacytoid dendritic cell marker 
CD80 costimulatory molecule on antigen presenting cells 
 
Statistical Analysis: 
Error bars on graphs represent the standard error of the mean. A one-way 
ANOVA followed by the Newman-Keuls Multiple Comparison Test was used in 
determining statistical significance between strains. 
Table 1 
Description of cell 
surface markers. 
Results: 
1. Lymph node CD4 levels are elevated in the SJL strain 
As can be seen in Table 2, lymph node CD4 levels are higher in both male and 
female SJL mice, compared to levels in B10.PL and C57BL/6 strains. The SJL strain also 
has a greater percentage of CD3+ cells. Thus, the SJL strain has an increased level of all 
T-cells, including the CD4+ T-helper cells, which mediate EAE. Interestingly, the SJL 
strain shows a lower proportion of cells bearing the CD19 marker which is specific for B-
cells. A graphical representation of the data can be seen in Fig. 2. 
The differences between the strains were only seen in lymph nodes and not in the 
spleen (data not shown). Also, no differences were seen in populations of T-regulatory 
cells (bearing CD25), dendritic cells or macrophages (data not shown). 
Strain CD4 CD8 CD3 CD19 
SJL (F) 53.97** 32.03 84.96* 2.17** 
SJL (M) 52.16** 31.86 84.46* 2.93** 
C57 (F) 34.07 26.52 61.36 8.45 
C57 (M) 33.09 25.54 62.12 9.62 
B10 (F) 31.93 20.89 49.85 10.62 
B10 (M) 32.59 22.43 56.38 13.97* 
 
2. Differences are not seen between sexes 
 While clear differences can be seen between the sexes when noting the clinical 
disease pattern (Fig. 1), no significant differences were noted in T-cell phenotypes 
between the sexes (Fig. 2). As EAE is mediated through the action of T-cells, this 
suggests that the sexual dimorphism seen during disease is due to factors that occur after 
immunization for EAE. However, it should be noted that greater percentages of CD19+ 
cells were seen in B10.PL males  compared to  females. 
Table 2 
The SJL strain shows statistically significant i
percentage of CD4+ and CD3+ cell populatio
males and females. The SJL strain has a statist
significant decrease relative to the other two st
CD19+ cells.  
(n=4 for CD4, n=2 for all other markers) 
* denotes p < .05 
** denotes p < .001 
* denotes p < .01 (increase in B10.PL male ov
































Comparison of cell surface markers in 
















Levels of CD4+ (T-helper cells), CD8+ (cytotoxic T-cells), CD3+ (T-cells) and 
CD19+ (B-cells) populations in lymph nodes of SJL, C57BL/6 and B10.PL mice. 
* denotes significant difference between SJL and C57BL/6 (Females and Males) 
** denotes significant difference between SJL and B10.PL (Females and Males) 





Naïve male and female mice of the SJL strain have significantly greater numbers 
of CD3+ and CD4+ lymph node cells and fewer lymph node B-cells relative to mice of 
the C57BL/6 and B10.PL (B cells only) strains. No sex differences are seen in lymph 
node or spleen cell populations of naïve mice from the three strains. 
The differences we observed in the SJL strain can be explained in part by some 
anomalies reported for the strain. The SJL strain has a reduced repertoire of T-cell 
receptors (TcR), as well as a deficiency in CD4+, NK1.1+ T-cells which produce the 
immunosuppressive cytokine IL-4 (Yoshimoto et al., 1995). However, within this 
reduced pool of receptor specificity, there is an increase in T-cells which recognize the 
neuroantigen peptide PLP (139-151), used to induce EAE (Anderson et al., 2000). The 
present findings can be explained in the context of these factors. Due to the reduced 
repertoire of T-cell types, our hypothesis is that there is an overcompensation of CD4+ 
cells to counter balance the loss in receptor diversity. A similar homeostatic mechanism 
may also account for the comparative decrease in B-cells which corresponds to an 
increase in T-cells.  
It has been shown that the SJL strain develops EAE and still exhibits sexual 
dimorphism, without the use of the adjuvant pertussis toxin (PT) (Papenfuss et al., 2004). 
We speculate that because of the increase in CD4+ cells, the SJL strain is susceptible to 
disease without the need for PT to amplify the immune response. The cytokine IL-10 has 
been suggested as a mechanism that protects the SJL from spontaneous EAE (Anderson 
et al., 2004). 
B10.PL and C57BL/6 strains present few differences in the naïve state. This can 
be linked to their clinical pattern by noting that these strains show few periods of relapse 
and remission during their disease course. Therefore, the increased CD4+ populations 
seen in the SJL strain may play a role in the relapsing-remitting disease pattern observed 
for this mouse.  
In this study, we have used three highly inbred mouse strains. We view these 
mouse strains as examples of individual human responses, with the SJL representing an 
individual highly susceptible to autoimmunity. The implications of this study aid in 
designing a model which could be used to analyze susceptible individuals and to predict 
their likely disease course for autoimmune disease. These findings suggest that 
individuals with increased numbers of T-cells could proceed along a RRMS disease 
course, similar to the SJL strain. Susceptible individuals with more normal T-cell 
numbers may demonstrate a disease pattern with less fluctuation, such as PPMS, as seen 
in the B10.PL and C57BL/6 strains. 
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